Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621735 · ClinicalTrials.gov registry record · NA
Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03621735 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 100 participants.
The verdict
NCT03621735, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of the study is to reduce tinnitus (ringing in the ear) loudness and improve the quality of life for those that are affected by tinnitus. This study will enroll subjects who have constant and bothersome tinnitus with no greater than a mild hearing loss up to 6 kHz, and no greater than a moderate hearing loss in the tinnitus frequencies. Subjects must also have the ability to alter the loudness or pitch of the ringing in their ears by performing a head, neck, face, or upper body movement. Subjects will be given both the treatment and sham arms (the study will randomly assign which arm is administered first) and will have a washout period of 6 weeks after each arm. The study will take approximately 36 weeks for subjects to complete and will enroll up to 300 individuals.
Interventions
- DEVICE Burst-SCS/sham SCS
- DEVICE Sham SCS/Burst-SCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2022-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621735
The ClinicalTrials.gov registry entry for NCT03621735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Burst-SCS/sham SCS is the first listed.
NCT03621735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621735 about?
NCT03621735 is a clinical study titled "Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts". The goal of the study is to reduce tinnitus (ringing in the ear) loudness and improve the quality of life for those that are affected by tinnitus. This study will enroll subjects who have constant and bothersome tinnitus with no greater than a mild hearing loss up to 6 kHz, and no greater than a mod...
What is the current status of trial NCT03621735?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-11-01. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT03621735?
The interventions under investigation include: Burst-SCS/sham SCS (DEVICE), Sham SCS/Burst-SCS (DEVICE).
Who is sponsoring clinical trial NCT03621735?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.